

Fundamental dimension Equity attribute | BZFDPeer $0.9643▼-0.59% Cap $84.47MP/E -0.6x QuantScore22/100 | KORELeader $9.250.00% Cap $163.0MP/E -2.4x QuantScore44/100 | LVOPeer $2.79▲+10.28% Cap $38.26MP/E -1.6x QuantScore37/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
35/100 |
69/100 |
60/100 |
Valuation Multiples, PEG & DCF upside | 33/100 | 41/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 16/100 | 26/100 | 23/100 |
Growth Revenue / earnings growth & margins | 9/100 | 42/100 | 4/100 |
Sentiment Analyst ratings, targets & revisions | 16/100 | 43/100 | 100/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.6x | -2.4x | -1.6x |
Forward P/E (next FY) | -2.4x | -6.8x | -2.4x |
EV / EBITDA (TTM) | -2.8x | 20.0x | -3.2x |
Price / Sales | 0.5x | 0.6x | 0.5x |
Price / Free Cash Flow | -4.2x | 8.9x | -3.0x |
PEG ratio | 0.00 | -0.07 | -0.06 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | 3 / 9 | 3 / 9 |
Altman Z-Score | -6.15 (Distress) | -1.63 (Distress) | -7.66 (Distress) |
Total debt / equity | 0.99 | -2.31 | -1.05 |
Quick ratio | 1.0x | 1.0x | 0.6x |
Interest coverage | -4.1x | -0.2x | -3.9x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -2.4% | -0.0% | -32.6% |
Net income growth YoY | -471.8% | +56.9% | -12.1% |
Gross margin (TTM) | 39.2% | 51.8% | 17.1% |
Operating margin (FY) | -7.1% | -4.4% | -20.1% |
FCF margin (FY) | -11.2% | 3.0% | -17.8% |
5. Trailing price performancePrice change over period |
1M return | -6.4% | 0.0% | +18.7% |
3M return | -13.1% | +0.8% | -42.7% |
6M return | +29.6% | +77.2% | -45.1% |
Year to date | +3.7% | +119.2% | -40.9% |
1Y return | -44.6% | +287.0% | -49.7% |
3Y return | -16.1% | +150.0% | -73.4% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-4.11 -526.5% premium | $-0.0306 -100.3% premium | $-6.88 -346.6% premium |
Wall Street consensus target | $1.00 +3.7% · range $1.00–$1.00 | — — | $9.50 +240.5% · range $8.00–$11.00 |
Consensus stance | 33% Buy33% Hold33% Sell | 56% Buy44% Hold0% Sell | 100% Buy0% Hold0% Sell |